Avanir Pharmaceuticals, INC.
Biopharmaceutical research and manufacturing.
Based in CA
AI Overview
With $330K in lobbying spend across 10 quarterly filings, Avanir Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $180K |
| 2022 | $150K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Avanir Pharmaceuticals, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Access to and innovation in biopharmaceuticals, including through policies related to payment, pricing, and clinical trials.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.